Indonesian Rupiah: Softer Dollar offers limited relief – OCBC

Source Fxstreet

OCBC strategists Sim Moh Siong and Christopher Wong note that Indonesian Rupiah (IDR) should find some relief from a softer Dollar and lower long-end US yields, with BI keeping its policy rate at 5.75% and focusing on currency stability. BI is increasingly relying on non-rate tools like FX hedging incentives and SRBI. USD/IDR shows bearish momentum, with support at 17760 and 16630 and resistance at 17940.

BI holds rates, uses non-rate tools

"IDR is likely to find some relief from the softer USD and pullback in long-end US Treasury yields. Yesterday, BI kept its policy rate unchanged at 5.75% and maintained its focus on IDR stability, while reiterating measures to attract foreign inflows and deepen FX markets."

"The decision also reinforces policy continuity under acting Governor Destry Damayanti. BI appears increasingly inclined to rely on non-rate tools, including FX hedging incentives and SRBI, rather than pushing domestic rates materially higher."

"Near term, a sustained USD pullback would ease some external pressure on IDR, although elevated oil prices remain a constraint for Indonesia."

"USD/IDR last closed at 17830 levels. Bearish momentum on daily chart intact while RSI is flat for now. 2-way trades likely."

"Support at 17760, 16630 levels (100 DMA, 38.2% fibo retracement of 2026 low to high). Resistance at 17940 (21, 50 DMAs)."

(This article was created with the help of an Artificial Intelligence tool and reviewed by an editor. Know more.)

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Why the S&P 500’s Path to 9,000 Runs Into Trouble in 2027The boldest S&P 500 forecast on Wall Street sees 9,000 by year-end, roughly 17% above where the index trades now. The fuel is the AI boom and a wall of idle cash.The warning is that the same AI trade
Author  Beincrypto
19 hours ago
The boldest S&P 500 forecast on Wall Street sees 9,000 by year-end, roughly 17% above where the index trades now. The fuel is the AI boom and a wall of idle cash.The warning is that the same AI trade
placeholder
Treasury Just Drew a Line in the Sand at 5.3%, and Bitcoin NoticedThe US Treasury said Wednesday it will at least double the size of its long-end debt buybacks. The 30-year yield reversed sharply from a 19-year high, and Bitcoin climbed past $65,000.The larger opera
Author  Beincrypto
19 hours ago
The US Treasury said Wednesday it will at least double the size of its long-end debt buybacks. The 30-year yield reversed sharply from a 19-year high, and Bitcoin climbed past $65,000.The larger opera
placeholder
Crypto Prices Explode With Surprise Rally: Is the Bull Market Back? Bitcoin (BTC) jumped 5.8% to levels above $69,500 on Wednesday, wiping out $1.23 billion in bets against it in one hour. Is the crypto bull market back?The rally ran market-wide, with Ethereum (ETH) u
Author  Beincrypto
19 hours ago
Bitcoin (BTC) jumped 5.8% to levels above $69,500 on Wednesday, wiping out $1.23 billion in bets against it in one hour. Is the crypto bull market back?The rally ran market-wide, with Ethereum (ETH) u
placeholder
Bitcoin is a “Cheat Code” to Retire Without Selling, Analyst Explains WhyBitcoin functions as a genuine cheat code for retiring without ever selling, according to analyst and entrepreneur Mark Moss, who laid out that thesis in a recent Coin Stories podcast interview.His ce
Author  Beincrypto
19 hours ago
Bitcoin functions as a genuine cheat code for retiring without ever selling, according to analyst and entrepreneur Mark Moss, who laid out that thesis in a recent Coin Stories podcast interview.His ce
placeholder
Eli Lilly Price Forecast: The Next Big Stock After Weight-Loss Drug Breakthrough?Eli Lilly is one of the most popular names today in America’s weight-loss and diabetes drug market. Its drugs delivered an average weight loss of 28.3% in a Phase 3 trial, approaching results historic
Author  Beincrypto
19 hours ago
Eli Lilly is one of the most popular names today in America’s weight-loss and diabetes drug market. Its drugs delivered an average weight loss of 28.3% in a Phase 3 trial, approaching results historic
goTop
quote